Patrick McIlvenny - Nov 11, 2022 Form 3 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role: Chief Accounting Officer
Signature: /s/ Patrick McIlvenny
Stock symbol: HZNP
Transactions as of: Nov 11, 2022
Transactions value $: $0
Form type: 3
Date filed: 11/14/2022, 03:13 PM
Next filing: Jan 6, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	HZNP	Ordinary Shares						2.49K	Nov 11, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	HZNP	Restricted Stock Units (RSU)							Nov 11, 2022	Ordinary Shares	3.87K		Direct	F1
holding	HZNP	Restricted Stock Units (RSU)							Nov 11, 2022	Ordinary Shares	4.4K		Direct	F2
holding	HZNP	Restricted Stock Units (RSU)							Nov 11, 2022	Ordinary Shares	5.71K		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. The 3,871 ordinary shares subject to the restricted stock units vest on January 5, 2023.
F2	Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. 2,198 ordinary shares subject to the restricted stock units vest on January 5, 2023; and 2,198 ordinary shares subject to the restricted stock units vest on January 5, 2024.
F3	Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. 1,904 ordinary shares subject to the restricted stock units vest on January 5, 2023; 1,904 ordinary shares subject to the restricted stock units vest on January 5, 2024; and 1,905 ordinary shares subject to the restricted stock units vest on January 5, 2025.